Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D2J4YT
|
|||
| Drug Name |
211At-labelled aLAT-1
|
|||
| Drug Type |
Radiopharmaceutical therapy agent
|
|||
| Indication | Multiple myeloma [ICD-11: 2A83; ICD-10: C90] | Preclinical | [1] | |
| Company |
Telix Pharma
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Radiopharmaceutical therapy in cancer: clinical advances and challenges. Nat Rev Drug Discov. 2020 Sep;19(9):589-608. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.